Changes in peak oxygen consumption in Fabry disease and associations with cardiomyopathy severity
Roy, Ashwin Thompson, Sophie E Hodson, James van Vliet, Jan Condon, Nicola Alvior, Amor Mia O'Shea, Christopher Vijapurapu, Ravi Nightingale, Tom E Clift, Paul F
Roy, Ashwin
Thompson, Sophie E
Hodson, James
van Vliet, Jan
Condon, Nicola
Alvior, Amor Mia
O'Shea, Christopher
Vijapurapu, Ravi
Nightingale, Tom E
Clift, Paul F
Abstract
This was a retrospective observational study of adults with FD undergoing cardiopulmonary exercise testing (CPEX) between September 2011 and September 2023 at a national referral centre in the UK. The primary outcome measure was peak oxygen uptake (V̇O2peak), with forced expiratory volume in 1 s (FEV1) used to quantify respiratory impairment. Age-normalised/sex-normalised values were additionally calculated, based on published normal ranges for subgroups of age and sex. The cardiomyopathy phase was classified on a 4-point scale by two FD experts using contemporaneous imaging and biochemistry results.
MIDER Authors
Citations
Altmetric:
Date
2024-11-25
Type
Article
Subject
Diseases & disorders of systemic, metabolic or environmental origin, Cardiology, Human physiology, Biochemistry, Clinical pathology
Collections
Citation
Roy A, Thompson SE, Hodson J, van Vliet J, Condon N, Alvior AM, O'Shea C, Vijapurapu R, Nightingale TE, Clift PF, Townend J, Geberhiwot T, Steeds RP. Changes in peak oxygen consumption in Fabry disease and associations with cardiomyopathy severity. Heart. 2025 Feb 12;111(5):230-238. doi: 10.1136/heartjnl-2024-324553.
Journal / Source Title
Heart
DOI
10.1136/heartjnl-2024-324553
PMID
39586663
Publisher
BMJ Publishing Group
Publisher’s URL
https://heart.bmj.com/content/early/2024/11/25/heartjnl-2024-324553.long